Key Financial Data Of Reporting Company

OncoTherapy Science, Inc. - Filing #7329199

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-873,356,000 JPY
-1,136,373,000 JPY
-1,086,234,000 JPY
-1,133,099,000 JPY
-2,011,350,000 JPY
-2,071,783,000 JPY
-1,336,660,000 JPY
-1,639,262,000 JPY
-1,790,856,000 JPY
-2,197,193,000 JPY
Profit (loss)
-1,007,782,000 JPY
-1,117,177,000 JPY
-2,426,231,000 JPY
-1,547,021,000 JPY
-1,977,563,000 JPY
Share capital
50,000,000 JPY
789,114,000 JPY
789,114,000 JPY
50,000,000 JPY
1,420,486,000 JPY
Total number of issued shares
217,643,700 xbrli:shares
192,643,700 xbrli:shares
192,643,700 xbrli:shares
176,332,000 xbrli:shares
176,332,000 xbrli:shares
Net assets
353,666,000 JPY
353,666,000 JPY
574,812,000 JPY
855,169,000 JPY
1,980,233,000 JPY
1,698,410,000 JPY
3,076,822,000 JPY
2,649,689,000 JPY
4,728,481,000 JPY
4,286,733,000 JPY
Total assets
867,275,000 JPY
507,227,000 JPY
949,263,000 JPY
1,511,438,000 JPY
2,685,199,000 JPY
2,116,549,000 JPY
3,368,102,000 JPY
2,894,992,000 JPY
5,088,076,000 JPY
4,616,437,000 JPY
Net assets per share
1.28
1.28
2.58
4.04
9.84
8.38
16.96
14.53
25.81
23.31
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-4.74
-6.05
-5.80
-5.81
-12.94
-13.72
-8.77
-8.86
-12.13
-13.73
Diluted earnings per share
Equity-to-asset ratio
0.322 xbrli:pure
0.550 xbrli:pure
0.524 xbrli:pure
0.515 xbrli:pure
0.706 xbrli:pure
0.763 xbrli:pure
0.888 xbrli:pure
0.885 xbrli:pure
0.895 xbrli:pure
0.890 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,227,990,000 JPY
-794,901,000 JPY
-2,073,224,000 JPY
-1,762,629,000 JPY
-2,275,529,000 JPY
Net cash provided by (used in) investing activities
-33,354,000 JPY
-20,319,000 JPY
-467,928,000 JPY
-52,225,000 JPY
-30,700,000 JPY
Net cash provided by (used in) financing activities
671,365,000 JPY
95,950,000 JPY
1,478,967,000 JPY
JPY
2,164,089,000 JPY
Cash and cash equivalents
527,656,000 JPY
1,117,635,000 JPY
1,836,906,000 JPY
2,899,092,000 JPY
4,713,947,000 JPY
Number of employees
xbrli:pure
54 xbrli:pure
27 xbrli:pure
27 xbrli:pure
27 xbrli:pure
27 xbrli:pure
28 xbrli:pure
60 xbrli:pure
67 xbrli:pure
36 xbrli:pure
66 xbrli:pure
35 xbrli:pure
62 xbrli:pure
32 xbrli:pure
Average number of temporary employees
xbrli:pure
4 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
4 xbrli:pure
1 xbrli:pure
7 xbrli:pure
6 xbrli:pure
1 xbrli:pure
5 xbrli:pure
3 xbrli:pure
9 xbrli:pure
6 xbrli:pure
Total shareholder return
0.148 xbrli:pure
0.348 xbrli:pure
0.511 xbrli:pure
0.911 xbrli:pure
0.459 xbrli:pure
Total return on share price index
1.738 xbrli:pure
1.258 xbrli:pure
1.222 xbrli:pure
1.227 xbrli:pure
0.881 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.